When I first heard about the EpiPen price increases going up 500 percent, I was like anybody else, outraged.
They just don't understand why it costs 500 percent more, particularly when the ingredients are quite inexpensive.
It's kind of hard to get bureaucrats out of Washington.
Right. Some of the published material also said that Adrenaclick was not therapeutically equivalent to EpiPen.
We want to find the solution. If any of you are willing to continue to work with our office--several bills were mentione...
Maybe we should stop that--stop allowing a patent for that, because there is some discussion--like I remember in ophthal...
Maybe we should expedite things when there's only one person making something and the price goes up at an alarming pace.
The overarching question we have to ask is: Does the FDA care about drug prices?
Tough question. Obviously, the broad-brush stroke that most regulatory agencies take becomes a very, very difficult part...
We feel that we are in an ideal position, being in that $6.5 billion size, that we understand the needs of the community...
As you can imagine, the number of prepaid cards that are out in the marketplace right now creates a huge regulatory burd...